Cost-effectiveness of chemotherapy in non-small-cell lung cancer - In reply

被引：0
|
作者：
Leighl, NB [1 ]
Shepherd, FA
Goodwin, PJ
机构：
[1] Univ Toronto, Princess Margaret Hosp, Univ Hlth Network, Toronto, ON, Canada
[2] Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2002年 / 20卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：3751 / 3752
页数：2
相关论文
共 50 条
  • [21] Chemotherapy for non-small-cell lung cancer
    Satoh, H
    Sekizawa, K
    LANCET, 2001, 358 (9289): : 1270 - 1271
  • [22] Cost-Effectiveness of Surveillance Scanning Strategies after Curative Treatment of Non-Small-Cell Lung Cancer
    Wolff, Henri B.
    Alberts, Leonie
    Kastelijn, Elisabeth A.
    El Sharouni, Sherif Y.
    Schramel, Franz M. N. H.
    Coupe, Veerle M. H.
    MEDICAL DECISION MAKING, 2021, 41 (02) : 153 - 164
  • [23] COST-EFFECTIVENESS OF TREATMENT WITH NEW AGENTS IN ADVANCED NON-SMALL-CELL LUNG CANCER: A SYSTEMATIC REVIEW
    Bongers, Mathilda L.
    Coupe, Veerle M. H.
    Jansma, E. P.
    Smit, Egbert F.
    Uyl-de Groot, Carin A.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1225 - S1226
  • [24] COST-EFFECTIVENESS OF TREATMENT WITH NEW AGENTS IN ADVANCED NON-SMALL-CELL LUNG CANCER: A SYSTEMATIC REVIEW
    Bongers, M. L.
    Coupe, V. M.
    Jansma, E. P.
    Smit, E. F.
    Uyl-de Groot, C.
    VALUE IN HEALTH, 2011, 14 (07) : A451 - A451
  • [25] COST-EFFECTIVENESS ANALYSIS OF EGFR TESTING AND GEFITINIB FOR NON-SMALL-CELL LUNG CANCER (NSCLC) IN JAPAN
    Shiroiwa, T.
    Miyoshi, Y.
    Tsutani, K.
    VALUE IN HEALTH, 2012, 15 (04) : A67 - A67
  • [26] Modelling the cost-effectiveness of public awareness campaigns for the early detection of non-small-cell lung cancer
    S Hinde
    C McKenna
    S Whyte
    M D Peake
    M E J Callister
    T Rogers
    M Sculpher
    British Journal of Cancer, 2015, 113 : 135 - 141
  • [27] Modelling the cost-effectiveness of public awareness campaigns for the early detection of non-small-cell lung cancer
    Hinde, S.
    McKenna, C.
    Whyte, S.
    Peake, M. D.
    Callister, M. E. J.
    Rogers, T.
    Sculpher, M.
    BRITISH JOURNAL OF CANCER, 2015, 113 (01) : 135 - 141
  • [28] Cost-effectiveness of adjuvant chemotherapy with uracil-tegafur, an oral fluoropyrimidine derivative, in patients with non-small-cell lung cancer in Japan
    Ikeda, S
    Sakamaki, H
    Yajima, S
    Ikegami, N
    VALUE IN HEALTH, 2006, 9 (03) : A106 - A106
  • [29] A Trial-Based Cost-Effectiveness Analysis of Bevacizumab and Chemotherapy Versus Chemotherapy Alone for Advanced Nonsquamous Non-Small-Cell Lung Cancer in China
    Li, Xinyan
    Li, Weichen
    Hou, Lingping
    VALUE IN HEALTH REGIONAL ISSUES, 2019, 18 : 1 - 7
  • [30] Cost-effectiveness of adjuvant chemotherapy in resected non-small cell cancer
    Messori, Andrea
    Caccese, Erminia
    Cecchi, Michele
    Orsi, Cecilia
    Tendi, Enrico
    PHARMACY WORLD & SCIENCE, 2007, 29 (05): : 486 - 486
12345